XML 15 R5.htm IDEA: XBRL DOCUMENT v3.22.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive (Loss) Income
Beginning balance (in shares) at Dec. 31, 2020   91,502,461      
Beginning balance at Dec. 31, 2020 $ 130,670 $ 915 $ 1,176,647 $ (1,046,889) $ (3)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Recognition of stock-based compensation 1,099   1,099    
Exercise of stock options (in shares)   31,811      
Exercise of stock options 79 $ 1 78    
Unrealized gain (loss) on marketable securities (6)       (6)
Net loss (9,927)     (9,927)  
Ending balance (in shares) at Mar. 31, 2021   91,534,272      
Ending balance at Mar. 31, 2021 $ 121,915 $ 916 1,177,824 (1,056,816) (9)
Beginning balance (in shares) at Dec. 31, 2021 91,645,369 91,645,369      
Beginning balance at Dec. 31, 2021 $ 90,707 $ 916 1,182,225 (1,092,325) (109)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Recognition of stock-based compensation $ 1,718   1,718    
Exercise of stock options (in shares) 0 0      
Exercise of stock options $ 0 $ 0 0    
Unrealized gain (loss) on marketable securities (342)       (342)
Net loss $ (16,109)     (16,109)  
Ending balance (in shares) at Mar. 31, 2022 91,645,369 91,645,369      
Ending balance at Mar. 31, 2022 $ 75,974 $ 916 $ 1,183,943 $ (1,108,434) $ (451)